Andrew R. Weckstein - Concepedia

Author

Andrew R. Weckstein

Aetion (United States)ORCID

Also Known As

A. Weckstein, Andrew R Weckstein, Andrew R. Weckstein, Andrew Weckstein

Publications

Citations

H-Index

Concepts

All Affiliations

Aetion (United States)Harvard University Brigham and Women's Hospital Janssen (United States)United States Food and Drug Administration

About

Andrew R. Weckstein is an author at Aetion (United States) specializing in covid-19, medicine, and preventive medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	843
2	Public Health	2	2	49
3	Epidemiology	2	2	49
4	Health Policy	1	1	18
5	Immunology	1	1	794

Andrew R. Weckstein

Publications

Citations

H-Index

Page 1

	Year	Citations
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms David E. Gordon, Joseph Hiatt, Mehdi Bouhaddou, Science Viral DiagnosticsCovid-19 PandemicViral PathogenesisImmunologyMolecular Biology	2020	794
Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study William Murk, Monica Gierada, Michael Fralick, Canadian Medical Association Journal	2020	66
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech, JAMA Network Open	2022	58
Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech, Population Health SciencesCovid-19 EpidemiologyDelta VariantVaccine HesitancyCovid-19	2021	31
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021 Marie C. Bradley, Silvia Pérez-Vilar, Yoganand Chillarige, JAMA	2022	25
Categorization of <scp>COVID</scp>‐19 severity to determine mortality risk Elizabeth M. Garry, Andrew R. Weckstein, Kenneth Quinto, Pharmacoepidemiology and Drug Safety	2022	21
Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US Maria C. Schneeweiss, Sandra Leonard, Andrew R. Weckstein, HypertensionDhpccb UsersPharmacotherapyCovid-19 EpidemiologyCovid-19	2020	18
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients Mark Stewart, Carla Rodriguez‐Watson, Adem Albayrak, PLoS ONE	2021	13

Page 1